1-4 of 4
Francis R DeGuzman
Close
Sort by
Journal Articles

PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model

Michael P. Reilly, Uma Sinha, Pierrette André, Scott M. Taylor, Yvonne Pak, Francis R. DeGuzman, Nisha Nanda, Anjali Pandey, Moritz Stolla, Wolfgang Bergmeier, Steven E. McKenzie
Journal: Blood
Blood (2011) 117 (7): 2241–2246.
https://doi.org/10.1182/blood-2010-03-274969
Published: 2011
Includes: Supplemental data
Journal Articles

Recombinant Antidote for Reversal of Anticoagulation by Factor Xa Inhibitors.

Genmin Lu, PhD, Francis R. DeGuzman, Sanjay Lakhotia, PhD, Stanley J Hollenbach, David R Phillips, PhD, Uma Sinha, PhD
Journal: Blood
Blood (2008) 112 (11): 983.
https://doi.org/10.1182/blood.V112.11.983.983
Published: 2008
Journal Articles

Inhibition of Syk Activity Is Sufficient for Inhibitory Effect in Animal Models of Autoimmune Diseases

Stanley J Hollenbach, Greg Coffey, Francis R DeGuzman, Mayuko Inagaki, Anjali Pandey, Zhaozhong J Jia, Qing Xu, Shawn Bauer, Dale Baker, Nisha Nanda, David R Phillips, Uma Sinha
Journal: Blood
Blood (2008) 112 (11): 680.
https://doi.org/10.1182/blood.V112.11.680.680
Published: 2008
Journal Articles

PRT060318, a Novel Syk Inhibitor, Prevents Heparin-Induced Thrombocytopenia in a Transgenic Mouse Model

Michael P. Reilly, PhD, Uma Sinha, PhD, Pierrette Andre, Scott M. Taylor, MS, Yvonne Pak, PhD, Francis R. DeGuzman, Nisha Nanda, PhD, Anjali Pandey, PhD, Steven E. McKenzie, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 269.
https://doi.org/10.1182/blood.V112.11.269.269
Published: 2008